235 related articles for article (PubMed ID: 16337831)
1. Human cytomegalovirus vaccine: time to look for alternative options.
Khanna R; Diamond DJ
Trends Mol Med; 2006 Jan; 12(1):26-33. PubMed ID: 16337831
[TBL] [Abstract][Full Text] [Related]
2. Vaccine strategies against human cytomegalovirus infection.
Zhong J; Khanna R
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):449-59. PubMed ID: 17547509
[TBL] [Abstract][Full Text] [Related]
3. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee.
Arvin AM; Fast P; Myers M; Plotkin S; Rabinovich R;
Clin Infect Dis; 2004 Jul; 39(2):233-9. PubMed ID: 15307033
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.
Dasari V; Smith C; Khanna R
Expert Rev Vaccines; 2013 Jun; 12(6):661-76. PubMed ID: 23750795
[TBL] [Abstract][Full Text] [Related]
5. Induction of pluripotent protective immunity following immunisation with a chimeric vaccine against human cytomegalovirus.
Zhong J; Rist M; Cooper L; Smith C; Khanna R
PLoS One; 2008 Sep; 3(9):e3256. PubMed ID: 18806877
[TBL] [Abstract][Full Text] [Related]
6. Location, location, timing: analysis of cytomegalovirus epitopes for neutralizing antibodies.
Schrader JW; McLean GR
Immunol Lett; 2007 Sep; 112(1):58-60. PubMed ID: 17714794
[TBL] [Abstract][Full Text] [Related]
7. A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.
Heineman TC; Schleiss M; Bernstein DI; Spaete RR; Yan L; Duke G; Prichard M; Wang Z; Yan Q; Sharp MA; Klein N; Arvin AM; Kemble G
J Infect Dis; 2006 May; 193(10):1350-60. PubMed ID: 16619181
[TBL] [Abstract][Full Text] [Related]
8. Effect of serum and CTL on focal growth of human cytomegalovirus.
Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G
J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
Rölle A; Olweus J
APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donor.
Grigoleit GU; Kapp M; Hebart H; Fick K; Beck R; Jahn G; Einsele H
J Infect Dis; 2007 Sep; 196(5):699-704. PubMed ID: 17674311
[TBL] [Abstract][Full Text] [Related]
11. Prospects of a vaccine for the prevention of congenital cytomegalovirus disease.
Plachter B
Med Microbiol Immunol; 2016 Dec; 205(6):537-547. PubMed ID: 27519596
[TBL] [Abstract][Full Text] [Related]
12. Could a vaccine against immune-evading cytomegalovirus become a reality?
Emery VC
Expert Rev Vaccines; 2011 Aug; 10(8):1109-11. PubMed ID: 21854303
[No Abstract] [Full Text] [Related]
13. Rhesus cytomegalovirus a nonhuman primate model for the study of human cytomegalovirus.
Yue Y; Barry PA
Adv Virus Res; 2008; 72():207-26. PubMed ID: 19081492
[TBL] [Abstract][Full Text] [Related]
14. Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease.
Fu TM; An Z; Wang D
Vaccine; 2014 May; 32(22):2525-33. PubMed ID: 24681264
[TBL] [Abstract][Full Text] [Related]
15. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
Gerna G; Lilleri D
Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
[TBL] [Abstract][Full Text] [Related]
16. Adoptive immunotherapy of HCMV infection.
Kapp M; Tan SM; Einsele H; Grigoleit G
Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875
[TBL] [Abstract][Full Text] [Related]
17. Progress toward developing a cytomegalovirus vaccine.
Marshall GS; Plotkin SA
Infect Dis Clin North Am; 1990 Jun; 4(2):283-98. PubMed ID: 2161034
[TBL] [Abstract][Full Text] [Related]
18. Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy.
Xia L; Su R; An Z; Fu TM; Luo W
Hum Vaccin Immunother; 2018 Feb; 14(2):292-303. PubMed ID: 29053403
[TBL] [Abstract][Full Text] [Related]
19. Towards a novel vaccine against human cytomegalovirus based on a chimeric Ad5F35 adenovirus vector expressing the immunodominant antigenic domain 1 epitope.
Zhao P; Ma D; Yan S; Shao N; Zhang J; Bi Z; Dai J; Ji M; Ji C
Intervirology; 2009; 52(1):35-42. PubMed ID: 19372702
[TBL] [Abstract][Full Text] [Related]
20. [Cytomegalovirus infection in pregnancy].
Pusztai R
Orv Hetil; 2009 May; 150(21):963-8. PubMed ID: 19443304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
